What does Biotech do?

Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company founded in 1996 and headquartered in Genome Valley, Hyderabad. The company specializes in the research, development, manufacturing, and marketing of vaccines and biotherapeutics. With a workforce of over 700 employees and more than 145 global patents, Bharat Biotech has delivered billions of vaccine doses worldwide, focusing on innovative and cost-effective solutions for public health, particularly in developing regions. Bharat Biotech has achieved significant milestones, including the launch of India's first probiotic yeast and the development of WHO pre-qualified vaccines such as ROTAVAC® and Typbar TCV®. The company is also known for Covaxin, one of India's first indigenous COVID-19 vaccines. Its product portfolio includes a range of vaccines targeting various infectious diseases, as well as biotherapeutics like REGEN-D® for wound healing. Bharat Biotech emphasizes comprehensive lifecycle control from research to distribution, ensuring high standards in manufacturing and global commercialization.